One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 170,000 shares of Pfizer Inc. (NYSE: PFE) on Thursday, as the price of this fund was down over 1% in the day’s session. It is still up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 173,579 shares of Pfizer. At Thursday’s closing price, this would have valued this purchase at roughly $8.2 million. This is only a small fraction of the total holdings. The fund is up 36% over the past 52 weeks.
Check out all the ARK Invest buys for Thursday:
|ARKG||DYNS||DYNAMICS SPECIAL PURPOSE||1,696|
|ARKG||CMIIU||CM LIFE SCIENCES II||25,000|
|ARKQ||KTOS||KRATOS DEFENSE & SECURITY SOLUTIONS||201,508|
|ARKQ||ACIC||ATLAS CREST INVESTMENT||460,000|
|ARKX||PRNT||3D PRINTING ETF||12,670|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.